	Thrombotic Risk of Targeted Therapies in Breast Cancer: A Real-World Cohort Study. Res Sq Boland W, Guzik G, Grinsztejn E, Perez JA, Plevniak K, Bannow BS, Nayak L, Martin J. PMID: 42926660 [PubMed]
	Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S. PMID: 42926595 [PubMed]
	Explainable WinDWS-SwinNet: Optimizing Ultrasound Deep Radiomics for Multipathology Breast Lesion Classification. Acad Radiol Sharma D, Chauhan S. PMID: 42926176 [PubMed - as supplied by publisher]
	Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1â€’Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. Ann Oncol Rugo HS, Kok M, Goncalves A, Loirat D, Bianchini G, Fasching PA, Cescon DW, Díaz RR, Zagouri F, Korbenfeld E, Dalenc F, Gilarranz YJ, Hashimoto J, Park YH, Im SA, Hu X, Hirshfield KM, Jia L, Tryfonidis K, Schmid P. PMID: 42926111 [PubMed - as supplied by publisher]
	Atirmociclib and fulvestrant for patients with HR+/HER2- advanced/metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial. Ann Oncol Giordano A, Xu B, Yoshinami T, Huang CS, Park YH, Lerzo GL, Li H, Shai A, Jaliffe GG, Itoh M, Williams A, Goel S, Im SA, Cobb P, Golmakani M, Liu F, Moss RA, Vana A, Ignatiadis M, Rugo HS. PMID: 42926110 [PubMed - as supplied by publisher]
	Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy. Ann Oncol Kalinsky K, Wander SA, Hamilton E, Graff SL, Jeselsohn R, Park KH, Demirci U, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Ravenberg E, Amdur S, Litchfield LM, Bianchini G. PMID: 42926108 [PubMed - as supplied by publisher]
	Comparative assessment of skin toxicity in prone vs supine positions during postoperative breast radiotherapy: A systematic review and meta-analysis. Cancer Treat Res Commun Sawaira F, Khalid AA, Qazi H, Kukreja S, Yasir M, Hayat S, Waqas M, Junaid M, Shahab SH, Gul O, Mughees M, Sajid MS, Farooq U, Ur Rehman M, Arsalan M. PMID: 42925844 [PubMed - as supplied by publisher]
	DIEP versus SIEA flap in autologous breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg Morelli Coppola M, Brunetti B, Mureddu CP, Scarabosio A, Jaber GJ, di Summa PG, Tenna S, Persichetti P. PMID: 42925712 [PubMed - as supplied by publisher]
	Efficacy of an AIMP1-Derived Peptide (NeoPep-S) for Radiation-Induced Dermatitis in Breast Cancer Patients: A Prospective Randomized Active-Controlled Trial. Aesthetic Plast Surg Kim MJ, Kim HG, Han HM, Lim HS, Park YJ, Lee IJ. PMID: 42925326 [PubMed - as supplied by publisher]
	Screening Digital Breast Tomosynthesis Performance across Age Groups: Analysis of 302â€‰700 Examinations. Radiol Imaging Cancer Lamb LR, Mercaldo S, Destounis S, Bahl M. PMID: 42925141 [PubMed - indexed for MEDLINE]
	Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer: The HORIZON-Breast06 Randomized Clinical Trial. JAMA Fan Y, Liu Y, Wang Y, Ouyang Q, Zhang Q, Cui J, Li J, Ding Q, Wu X, Wang X, Tong Z, Zeng Y, Wang W, Yan M, Wang Y, Liu X, Li K, Sun Z, Yuan C, Wang T, Xie W, Yao J, Zhou S, Hou J, Ouyang Z, Li Y, Cui S, Zhang X, Zhu X, Xu B. PMID: 42925007 [PubMed - as supplied by publisher]
	The Role of Long Non-Coding RNAs in Breast Cancer Diagnosis and Treatment Based on Evidence from Clinical Studies: A Scoping Review. Epigenomes Zafrakas M, Papasozomenou P, Gavalas I, Emmanouilidis C, Chatzidimitriou M. PMID: 42924724 [PubMed]
	Advances in resistance mechanisms and counterstrategies for antibodyâ€‘drug conjugates in HER2â€‘low and HER2â€‘ultralow breast cancer (Review). Oncol Rep Yu X, Ren M, Yao L. PMID: 42924615 [PubMed - indexed for MEDLINE]
	Employment after curative breast cancer treatment: the breast cancer and the workforce cohort study. J Natl Cancer Inst Blinder VS, Sampathkumar Y, Patil S, Eberle CE, Suarez J, Narang B, Osorio VL, Filgueira AV, Finik J, Bennett AV, Malik MK, Jung GH, Hwang C, Gany F. PMID: 42924356 [PubMed - as supplied by publisher]
	RE: Endocrine therapy in early-stage estrogen receptor-low breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst Zhu L, Liu L. PMID: 42924349 [PubMed - as supplied by publisher]
	A Parameterization Framework for Image-Based Resolution Modeling of Spatially-Variant PSF Deformation in Dedicated Breast PET. IEEE Trans Radiat Plasma Med Sci Gao M, Krishnamoorthy S, Raj J, Matej S, Surti S. PMID: 42923883 [PubMed]
	Imaging Assessment of Residual Disease in Clipped Target Lymph Nodes after Neoadjuvant Chemotherapy for Breast Cancer: A Node-Level Validation Study. Breast Care (Basel) Yamazaki M, Nakamura R, Hayama S, Yamada H. PMID: 42923841 [PubMed - as supplied by publisher]
	Racial inequality in access to breast reconstruction surgery in the Brazilian Unified Health System: an interrupted time series study, Brazil, 2010-2024. Epidemiol Serv Saude da Silva AR, Postali FAS. PMID: 42922928 [PubMed - indexed for MEDLINE]
	A pan-cohort transcriptional landscape of breast cancer maps subtype and microenvironmental programs. bioRxiv Arora S, Suresh R, Holland N, Glatzer G, Jensen M, Konnick EQ, Pritchard CC, Li Y, Parsons HA, Hurvitz SA, Holland EC. PMID: 42922546 [PubMed]
	Artificial Intelligence in Breast Cancer Diagnosis, Treatment, and Perioperative Management: A Systematic Review of Current Applications and Future Perspectives. Clin Ter Mostafa AF, Mady R, Abu Halimah JH, Hassan N, Elshebiny AA, Abdelazeem MAA, Salem LN, Abdrabo AA, Ibrahem M, Elzeiny A, Abdelaziz SMME, Hakami AH, Sayegh AA, Hegazy HA, Ahmed IS. PMID: 42922241 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 223396

Page 1 of 11170



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy